Male Reproductive and Urologic C… PNLE Questions

Introduction

The live published inventory contains exactly 17 original PNLE-style practice questions for Male Reproductive and Urologic Care. These items sit within NP4 — Medical-Surgical and cover BPH, prostate and testicular disorders, urologic surgery, and adult disease-related sexual function.

This topic trains decisions about recognizing obstructive urinary findings, identifying urgent testicular or postoperative complications, interpreting treatment responses, managing continuous bladder irrigation and bladder spasms, and discussing procedure-related sexual changes. The page excludes STIs, gynecologic care, and maternity, while adjacent topics include Renal and Urinary Disorders, Sexual Health, STIs, and GU Oncology.

This is a Tangerine pedagogical lens mapped across relevant competencies in the official five-subject PNLE TOS, not a separate official test subject. The 2025 Enhanced TOS provides broad competency relationships rather than a guaranteed weight for this microtopic, so the inventory should guide preparation without implying a fixed number of questions on any exam form.

Key concepts

Recognize obstructive urinary patterns
Recognize: Hesitancy, weak stream, straining, incomplete emptying, frequency, and nocturia can indicate lower urinary tract obstruction associated with BPH.
Decide: Assess the symptom pattern, bladder fullness, discomfort, urine output, and change from baseline; escalate when retention or deterioration is suspected.
Avoid: Labeling every urinary complaint as infection or normal aging without a focused assessment.
Prioritize sudden testicular findings
Recognize: Sudden severe testicular pain, rapid swelling, or an acute change in position requires prompt attention, even when the patient has few other findings.
Decide: Perform a focused assessment and obtain urgent evaluation according to the clinical pathway rather than delaying care for routine teaching.
Avoid: Reassuring the patient solely because the symptom is unilateral or because there is no reported fever.
Screen for concerning progression in prostate disease
Recognize: Persistent bone or back pain, new weakness or numbness, and new bowel or bladder changes can be important cues in a patient with prostate disease.
Decide: Compare with baseline, assess the functional impact, document the pattern, and report concerning clusters promptly.
Avoid: Declaring metastasis from one symptom or dismissing persistent pain as an unrelated musculoskeletal complaint.
Maintain safe continuous bladder irrigation after prostate surgery
Recognize: The nurse must interpret drainage, urine appearance, clots, catheter patency, patient discomfort, and the amount of irrigation being infused together.
Decide: Check the tubing and drainage system when output changes, assess the patient, and follow the prescribed protocol for obstruction, bleeding, or irrigation adjustments.
Avoid: Reporting drainage as urine without accounting for irrigation or ignoring a falling output while fluid continues to enter.
Respond systematically to bladder spasms
Recognize: Cramping, urgency, suprapubic discomfort, or leakage around a catheter may occur with bladder spasms, but obstruction and clot retention can produce similar distress.
Decide: Assess the catheter and tubing for kinks or blockage, evaluate drainage and discomfort, and use only ordered or protocol-based interventions.
Avoid: Increasing traction, forcing irrigation, or assuming that severe pain is an expected postoperative finding.
Explain procedure-related sexual changes accurately
Recognize: A reduced or absent forward semen volume after procedures involving the prostate or bladder neck may result from altered ejaculatory flow and does not automatically indicate loss of erection or sexual desire.
Decide: Ask privately which function concerns the patient, provide procedure-specific teaching, and address fertility or intimacy concerns without assumptions.
Avoid: Equating semen volume, ejaculation, erection, orgasm, and libido as one identical function.
Interpret treatment response and implant findings in context
Recognize: A testosterone result after GnRH-based therapy must be interpreted with the specific agent, treatment timing, adherence, and follow-up plan; after penile implantation, increasing pain, fever, drainage, urinary difficulty, or device concerns are warning cues.
Decide: Verify the clinical context, assess for complications, and communicate abnormal findings through the appropriate pathway.
Avoid: Calling hormonal treatment a failure from one isolated result or treating postoperative implant concerns as merely expected discomfort.

What to expect on the PNLE

The live inventory supports several question forms: recognition of prostate or gland function, identification of BPH findings and complications, postoperative priority decisions, continuous bladder irrigation management, bladder-spasm interventions, mechanism questions about semen changes, assessment for disease progression, and interpretation of treatment response. The cognitive work is clinical cue recognition followed by prioritization, mechanism matching, safety checking, and evaluation of competing actions.

Its live difficulty distribution is 4 easy, 9 medium, and 4 hard items. The Bloom distribution is 5 remembering, 8 applying, 1 evaluating, and 3 analyzing, so practice should include both direct recall and short clinical situations that require connecting findings to a nursing action.

Remembering: Retrieve gland functions, common procedure effects, and defining assessment cues.
Applying: Use catheter findings, urinary symptoms, pain patterns, and postoperative changes to choose the next safe nursing response.
Evaluating and analyzing: Weigh competing explanations, interpret treatment data in context, and identify the finding that changes priority.

Exact topic distribution varies by exam form. Use these questions to build transferable decisions across the official TOS competencies, not to predict a fixed microtopic appearance.

Study tips

Start with diagnostic practice. Complete the 17 questions without opening notes. Mark each response as confident, uncertain, or guessed, and classify the decision involved: BPH assessment, prostate or testicular disorder, urologic surgery, or sexual function.
Use focused retrieval by scope. For each category, recall the key cue, the immediate nursing assessment, the escalation threshold, and the unsafe action. Make a comparison table with these columns: condition or procedure | distinguishing cue | immediate nursing decision | safety check. Fill it from memory before checking references.
Review every rationale and error. For each missed or guessed item, write the cue you overlooked, the priority principle, why the correct option is safer, and why your selected distractor is weaker. Add a separate note for mechanism questions, such as altered urinary flow or treatment-response interpretation.
Retry with spacing. Return to the error notes after a delay and answer the same concepts in a new order without looking at the original explanation. Rebuild the table when you cannot explain the decision in one or two clear sentences.
Finish with mixed timed practice. Combine Male Reproductive and Urologic Care with its adjacent topics only after focused retrieval is stable. Under time pressure, identify the patient cue, determine whether there is an immediate safety threat, select the nursing action, and then check whether the option exceeds the nurse's role.

Common mistakes to avoid

Calling all frequency or nocturia an infection. The corrective cue is the full pattern: hesitancy, weak stream, incomplete emptying, and retention risk point toward obstruction and require assessment rather than an automatic infection label.
Reading continuous bladder irrigation drainage as urine output. Irrigation changes the meaning of the collection-bag volume. Interpret drainage with the irrigation volume, color, clot pattern, patient assessment, and unit protocol before deciding whether output is adequate.
Responding to bladder spasms without checking patency. Cramping and leakage may be caused by a spasm, but a kinked catheter or clot obstruction can create a safety problem. Inspect the system and assess drainage before using an ordered intervention.
Assuming reduced semen volume means complete sexual dysfunction. The safety principle is to separate ejaculation, erection, orgasm, libido, and fertility. Ask the patient which change occurred and give teaching tied to the procedure.
Declaring GnRH therapy ineffective from one testosterone result. The needed cue is context: identify the agent, timing, adherence, and planned follow-up. A result should be interpreted within the treatment plan rather than in isolation.
Delaying escalation for acute or postoperative red flags. Sudden severe testicular pain, new neurologic changes, fever, increasing wound pain, drainage, urinary difficulty, or penile-implant concerns require prompt assessment and communication through the clinical pathway.

Try a question

A real Male Reproductive and Urologic Care question from our bank. Give it a shot.

Hard

Three months after starting a GnRH agonist for metastatic prostate cancer, PSA continues rising and serum testosterone remains above the castrate range. Which interpretation is most appropriate?

A

Attribute the PSA rise to tumor activity without checking testosterone suppression

B

Continue the regimen because PSA alone is insufficient to judge treatment response

C

The intended androgen-suppression target has not been achieved

D

Increase the agonist dose from PSA without confirming adherence or testosterone target

Rationale

When managing metastatic prostate cancer, GnRH (gonadotropin-releasing hormone) agonists are prescribed to achieve androgen deprivation, which aims to lower serum testosterone into the castrate range (typically <50 ng/dL, but many guidelines recommend <20 ng/dL as an optimal target). Achieving and maintaining this level is crucial, as the majority of prostate cancers are initially androgen-dependent and respond to suppression of testosterone.

Option C is correct because the persistent elevation of both PSA (prostate-specific antigen) and serum testosterone above the castrate threshold after three months of treatment means the primary therapeutic objective (maximal androgen deprivation) has not been reached. This suggests the medication may be ineffective due to inadequate dosing, absorption issues, medication errors, or poor patient adherence. Evidence-based practice dictates that clinicians must confirm biochemical castration (by checking testosterone) before interpreting changes in PSA as true progression or resistance. This ensures subsequent management decisions (such as switching therapies, adding anti-androgens, or considering castration-resistant disease) are evidence-based and not premature.

Let's review why the other options are incorrect:

Option	Why This Is Incorrect
A	It is unsafe to attribute a PSA rise solely to disease activity without first confirming that androgen suppression has succeeded. Failure to achieve castrate testosterone negates the intended physiological effect of the treatment, so PSA must be interpreted in that context.
B	PSA alone is never sufficient for judging treatment response, especially within months of starting therapy. Both PSA trends and serum testosterone are required to differentiate between inadequate therapy and true treatment resistance.
D	Dose escalation without confirming patient adherence, injection technique, or actual testosterone suppression may expose the patient to risks without benefit. Safe, cost-effective care requires verifying that all standards of monitoring have been followed before changing doses or interventions.

Underlying nursing concepts include: safe medication management, monitoring both clinical and laboratory parameters for efficacy, and systematic problem-solving when therapy fails to produce expected results. When the desired outcome (castrate testosterone with falling PSA) is not achieved, the nurse's responsibility is to collaborate in exploring causes (e.g., missed doses, improper administration, drug formulation issues), reinforce patient teaching about adherence, and advocate for appropriate follow-up testing before any escalation of therapy or labeling the cancer as treatment-resistant.

Clinical pearl: Always cross-check both PSA and testosterone levels when assessing ADT response in prostate cancer. Remember the sequence: "Lower testosterone first, then interpret PSA."

European Association of Urology. (n.d.). Prostate cancer guideline—Follow-up. https://uroweb.org/guidelines/prostate-cancer/chapter/followup
Hinkle, Janice L., Cheever, Kerry H., & Overbaugh, Kristen J. (2022). Brunner & Suddarth's Textbook of Medical-Surgical Nursing (15th ed.). Wolters Kluwer. https://shop.lww.com/Brunner---Suddarth-s-Textbook-of-Medical-Surgical-Nursing/p/9781975161033

References and further reading

PRC Enhanced Table of Specifications for the Nurses Licensure Examination official
The current public competency and cognitive-level blueprint, effective from the November 2025 NLE onward.
Tangerine Prep PNLE Reviewer question bank
The live source for the published question count, question previews, rationales, and inventory distributions on this page.

How this page is built

The counts and distributions on this page come from Tangerine Prep's live published question bank. The source inventory was last updated on August 12, 2026.

The questions are original PNLE-style practice items, not recalled or leaked board questions. Topic scope follows Tangerine's pedagogical taxonomy and is mapped to the PRC 2025 Enhanced Table of Specifications, effective from the November 2025 NLE onward. Exact topic distribution varies by exam form.